At the FT’s US Pharma and Biotech Summit in New York City, 16th and 17th May, leaders from across the pharma landscape will gather to discuss some of the hottest topics in US pharma, includ
AbbVie has moved to shore up its pipeline following the loss of patent protection for its top-selling drug with a $10.1 billion deal to buy ImmunoGen and its marketed ovar
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio